6 minutes
The High Court has determined that Merck Sharp & Dohme was entitled to an interlocutory injunction preventing a competitor from selling a generic version of a patented drug prior to the expiry of an SPC in April 2023. The competitor, Mylan Ireland Limited, had claimed that the SPC was invalid an
7 minutes
The Supreme Court has held that a pharmaceutical company should have been granted an interlocutory injunction restraining a generic competitor from infringing its (now expired) Supplementary Protection Certificate (SPC) for a combined treatment for cholesterol. Outlining the factors which a court sh
SUBSCRIBE
